Search clinical trials for: CC-93538
Total 829 results
-
Celgene CorporationCompletedMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterRecruiting
-
Chang Gung Memorial HospitalRecruiting
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI); Janssen, LPRecruitingMultiple MyelomaUnited States, Canada
-
CelgeneCompletedMyelodysplastic SyndromeUnited States, Australia, Canada, Czechia, France, Germany, Italy, Korea, Republic of, Mexico, Poland, Sweden, United Kingdom, Belgium, Brazil, Denmark, Finland, Greece, Israel, Netherlands, Norway, Portugal, Spain, Turkey
-
University of WashingtonNovartis; Institute for Prostate Cancer Research (IPCR)Not yet recruitingCastration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
Thomas HopeCompletedProstate CancerUnited States
-
National Cancer Institute (NCI)CompletedNeurofibromatosis Type 1 | Recurrent Childhood Pilocytic Astrocytoma | Recurrent Childhood Visual Pathway GliomaUnited States, Canada, Australia, New Zealand
-
Weill Medical College of Cornell UniversityPOINT BiopharmaSuspendedProstate CancerUnited States
-
CelgeneCompletedAnemia, Sickle CellUnited States
-
La Jolla Pharmaceutical CompanyCompletedSepsis | Catecholamine-resistant Hypotension (CRH) | Distributive Shock | High Output ShockUnited States
-
Gilead SciencesCompletedMyeloid MalignanciesUnited States, Australia, United Kingdom
-
Peking Union Medical College HospitalActive, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Waldenstrom Macroglobulinemia | Refractory Waldenstrom MacroglobulinemiaUnited States
-
CelgeneCompletedRheumatoid ArthritisUnited States
-
CelgeneTriphaseCompletedGlioblastoma | Malignant GliomaUnited States, Canada
-
Children's Hospital of PhiladelphiaAgency for Healthcare Research and Quality (AHRQ); Devereux Center for Effective...Enrolling by invitation
-
Southeast Retina Center, GeorgiaGenentech, Inc.CompletedPolypoidal Choroidal VasculopathyUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedSecondary Acute Myeloid Leukemia | Alkylating Agent-Related Acute Myeloid LeukemiaUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)TerminatedAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Adult Acute Myeloid Leukemia in RemissionUnited States
-
Weill Medical College of Cornell UniversityRecruiting
-
CelgeneCompletedAnemiaUnited States, Belgium, Spain, United Kingdom, Austria, Canada, Germany, Portugal, France, Australia, Israel, Japan, Italy, Czechia, Poland, Turkey
-
Weill Medical College of Cornell UniversityNational Cancer Institute (NCI); United States Department of Defense; National... and other collaboratorsCompleted
-
National Cancer Institute (NCI)WithdrawnChronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States
-
Ankara City Hospital BilkentCompletedCoxarthrosis; PrimaryTurkey
-
M.D. Anderson Cancer CenterCelgene CorporationTerminatedGraft-versus-Host DiseaseUnited States
-
M.D. Anderson Cancer CenterRecruitingHodgkin Lymphoma | B-Cell Lymphoma | Relapsed B-cell NHLUnited States
-
National Cancer Institute (NCI)CompletedNeurofibromatosis Type 1 | Recurrent Primary Central Nervous System Neoplasm | Refractory Primary Central Nervous System Neoplasm | Recurrent Childhood Brain Stem Glioma | Recurrent Childhood Visual Pathway GliomaUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationTerminatedLeukemiaUnited States
-
AmgenCompletedParapsoriasisUnited States
-
Ramathibodi HospitalKhon Kaen UniversityCompleted
-
Northwestern UniversityNational Cancer Institute (NCI)WithdrawnBreast Carcinoma | Metastatic Malignant Neoplasm in the Brain | Metastatic Malignant Neoplasm in the LeptomeningesUnited States
-
CelgeneActive, not recruitingLymphoma, Non-HodgkinUnited States, Germany, Puerto Rico
-
National Cancer Institute (NCI)CompletedRecurrent Adult Burkitt Lymphoma | Recurrent Adult Lymphoblastic Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic Marginal Zone Lymphoma | Waldenstrom... and other conditionsUnited States
-
CelgeneCompletedLymphoma, Non-HodgkinUnited States, Spain, China, Belgium, France, United Kingdom, Israel, Turkey, Russian Federation, Italy, Brazil, Czechia, Portugal, Germany, Japan, Poland, Puerto Rico
-
M.D. Anderson Cancer CenterCelgene; Onyx Therapeutics, Inc.Terminated
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...Bristol-Myers Squibb Services Unlimited CompanyRecruitingSystemic Lupus Erythematosus | Systemic Sclerosis | Idiopathic Inflammatory MyopathyUnited States, France, Germany, Italy, Belgium, Spain
-
KAZM Pharmaceuticals Inc.McMaster UniversityNot yet recruiting
-
M.D. Anderson Cancer CenterCelgene CorporationActive, not recruitingLymphoma | LeukemiaUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
National Human Genome Research Institute (NHGRI)CompletedMental Retardation | Sleep Disorders, Circadian Rhythm | Developmental Delay Disorders | Chromosome Deletion | Self Injurious BehaviorUnited States
-
National Cancer Institute (NCI)Active, not recruitingCutaneous T-Cell Lymphoma | Peripheral T-Cell Lymphoma | Mature T-cell Malignancies | Relapsed/ Refractory T-cell MalignanciesUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationTerminatedHematologic DisorderUnited States
-
AmgenCompletedArthritis, PsoriaticUnited States, Spain, Netherlands, Canada, France, Russian Federation, Belgium, Austria, Germany, Italy, United Kingdom
-
M.D. Anderson Cancer CenterDaiichi SankyoRecruiting
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Genentech, Inc.; Brigham and Women's Hospital and other collaboratorsTerminatedWaldenstrom's MacroglobulinemiaUnited States
-
University of ArkansasCompletedMultiple MyelomaUnited States
-
Roswell Park Cancer InstituteGlaxoSmithKlineRecruiting
-
Stanford UniversityNational Cancer Institute (NCI)CompletedRecurrent Prostate CarcinomaUnited States
-
CelgeneNot yet recruitingMultiple MyelomaChina, Australia, United States, Argentina, Austria, Belgium, Brazil, Canada, Chile, Czechia, France, Germany, Greece, Hungary, India, Ireland, Italy, Japan, Korea, Republic of, Norway, Portugal, Romania, Spain, Sweden, Switzerland, Turkey, United Kingdom